Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

Mabwell Gets IND Approval for Promising CDH17-Targeting Cancer Drug 7MW4911
Date 06 August 2025

Mabwell Gets IND Approval for Promising CDH17-Targeting Cancer Drug 7MW4911

Mabwell Received a Green Signal for CDH17 Announcement Manwell, an innovative and leading biopharmaceutical company, the pioneer of the entire industry chain, declared that its proprietary CDH17...

Genvira, LabSkin, and NRC Collaborate to Develop Immunotherapies for Melanoma
Date 05 August 2025

Genvira, LabSkin, and NRC Collaborate to Develop Immunotherapies for Melanoma

Genvira and NRC were Highlighted for their Collaborative Project Announcement Genvira Biosciences Inc., a pioneering Canadian innovator in viral vectors, LabSkin Limited, a global leader in 3D i...

Silexion Reports Breakthrough Preclinical Results for KRAS-Targeted Cancer Therapy SIL204
Date 05 August 2025

Silexion Reports Breakthrough Preclinical Results for KRAS-Targeted Cancer Therapy SIL204

Silexion’s Robust Preclinical Data Dhowed Excellent Results Announcement Silexion Therapeutics Corp., a global clinical-stage biotechnology company developing RNA interference (RNAi) thera...

Zenara Pharma Gets FDA Approval for Generic Sertraline Capsules with 180-Day US Exclusivity
Date 05 August 2025

Zenara Pharma Gets FDA Approval for Generic Sertraline Capsules with 180-Day US Exclusivity

Zenara’s Final Approval for its New Capsules Announcement Zenara Pharma Private Limited, a pioneering biophore company, finally received approval from the FDA for its abbreviated new drug ...

Azenta and Frenova Partner to Boost Genomic Research in Kidney and Metabolic Diseases
Date 05 August 2025

Azenta and Frenova Partner to Boost Genomic Research in Kidney and Metabolic Diseases

Azenta and Frenova’s Partnership to Advance Genomic Research in Nephrology Announcement Frenova, a division of Fresenius Nephronomics and Medical Care, a renal precision medicine company, ...

In-vitro IBD Diagnostics Market Accelerates with Biomarker Breakthroughs And AI-Powered Precision Care in Gastrointestinal Testing
Date 05 August 2025

In-vitro IBD Diagnostics Market Accelerates with Biomarker Breakthroughs And AI-Powered Precision Care in Gastrointestinal Testing

According to Precedence Research, the global in-vitro inflammatory bowel disease diagnostics market size is expected to be worth around USD 3.02 billion in 2034, increasing from USD 1.84 billion in 20...

Alafair Biosciences Gets FDA Clearance for Versacoatâ„¢ Flowable Hydrogel for Nerve and Tendon Protection
Date 04 August 2025

Alafair Biosciences Gets FDA Clearance for Versacoatâ„¢ Flowable Hydrogel for Nerve and Tendon Protection

Alafair BioSceinces Received Confirmation for Versacoat™ Nerve Protector and Versacoat™ Tendon Protector Announcement Alafair Biosciences, a well-established medical device company r...

Moderna's Updated COVID-19 Vaccine Gets Green Light from European Commission
Date 04 August 2025

Moderna's Updated COVID-19 Vaccine Gets Green Light from European Commission

Moderna’s Updated COVID-19 Vaccine Received Approval from the European Commission Announcement Moderna Inc. received a commercial authorization from the European Commission on the updated ...

W Health Ventures Raises $70 Million to Support Healthcare Startups in India
Date 04 August 2025

W Health Ventures Raises $70 Million to Support Healthcare Startups in India

W Health Ventures Funded Millions to Develop Healthcare Innovation in India Announcement W Health Ventures has raised a $70 million fund for the second time to help healthcare startups build fro...

Xenetic and Periness Begin Clinical Study of DNase 1 with CAR T Therapy in Lymphoma Patients
Date 04 August 2025

Xenetic and Periness Begin Clinical Study of DNase 1 with CAR T Therapy in Lymphoma Patients

Xenetic and Periness Signed a ‘Clinical Study Agreement’ Announcement Xenetic Biosciences Inc., a leading biopharmaceutical company focused on developing and advancing innovative imm...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.